Skip to main content

Bracebridge Capital, LLC

Position in RNA — Atrium Therapeutics, Inc.

CIK 1426486 BOSTON, MA

Position in RNA

as of Mar 31, 2026 · filed May 15, 2026
Position Value
$1,861,625
New position
Shares Held
139,239
first reported quarter
Ownership
0.814%
of shares outstanding
% of Portfolio
0.34%
of 13F equity value
Holder Rank
not a current holder
Holding Since
Mar 2026
1 quarter on record
Voting authority Sole 100% Shared 0% None 0%

Position in Biotechnology

Healthcare · as of Mar 31, 2026

Bracebridge Capital, LLC holds $1,861,625 across 1 Biotechnology name. RNA ranks #1 (100.0% of the industry book) .

# Ticker Company Shares Value (USD) Open
1 RNA
Atrium Therapeutics, Inc.
This page
139,239 $1,861,625

All Filings in RNA

Export CSV
1 filing row on record
Report Date Value (USD) Shares
2026-03-31 $1,861,625 139,239